Aimsco Limited

Royaume‑Uni

Commandez votre montre hebdomadaire Aimsco Limited
Quantité totale PI 7
Rang # Quantité totale PI 229 906
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 754 556
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

0 0
1 1
5 0
0
 
Dernier brevet 2018 - Formulation comprising a stabili...
Premier brevet 2002 - Therapeutic agent
Dernière marque 2013 - AIMSPRO
Première marque 2013 - AIMSPRO

Industrie (Classification de Nice)

Derniers inventions, produits et services

2018 Invention Formulation comprising a stabilized complex of corticotropin releasing hormone and alpha-2 macrog...
2016 Invention Treatment of medical conditions. A composition comprising CRH, CRH binding protein (CRH-BP), alph...
2015 Invention Treatment of diseases. Provided are methods for the treatment of various neural disorders includ...
Invention Therapeutic agent. Anti-HLA and other antibodies are present in goat serum after injection of HI...
Invention Formulation and method of manufacture. The present invention relates to a CRH formulation and to ...
2014 Invention Improved formulation. The present invention relates to a CRH formulation having improved stabilit...
2013 Invention Use of goat serum for veterinary treatment. Methods for veterinary treatment of mammals are desc...
Invention Treatment of diseases. Methods of treatment of various non-demyelinating and demyelinating neura...
Invention Treatment of hiv. We describe methods of treatment of HIV using proopiomelanocortin (POMC) and c...
P/S Pharmaceutical preparations and substances for human and veterinary use, namely, anti-inflammator...
Invention Treatment of ms with goat serum. A serum composition from a goat immunised with HIV contains ant...
Invention Formulation comprising crh and alpha - 2 - immunoglobulin. The present invention relates to a CRH...
2012 Invention Use of goat serum for veterinary treatment. Methods for veterinary treatment of mammals are descr...
Invention Medicament. Analysis of a goat serum product with many therapeutic effects is described. The pro...
2010 Invention Use of a serum composition to reduce the levels of tnf and/or vegf in mammals. The invention rela...
2007 Invention Treatment of hiv. We describe methods of treatment of HIV using proopiomelanocortin (POMC) and co...
2006 Invention Combination therapy. The present invention describes a pharmaceutical composition comprising the ...
Invention Pharmaceutical composition comprising serum obtained from a naive mammal. Pharmaceutical composit...
Invention Bioactive compounds. Methods and compositions comprising bioactive molecules associated with anti...
2005 Invention Medicament. Analysis of a goat serum product with many therapeutic effects is described. The prod...
Invention Treatment of diseases. Methods of treatment of various non-demyelinating and demyelinating neural...
2003 Invention Treatment of ms with goat serum. A serum composition from a goat immunised with HIV contains anti...
2002 Invention Use of polyclonal anti-hiv goat serum as a therapeutic agent. Anti-HLA and other antibodies are p...